[1]
M. Hamid and Z. . Shahbazi, “Prevalence of JAK2 V617F Mutation in Iranian Patients with Myeloproliferative Neoplasms”, Arch Med Lab Sci, vol. 6, no. 1, pp. 1–7 (e5), Nov. 2020.